Sodium Glucose Co-transporter Inhibitors in Patients with Acromegaly and Diabetes.
This article highlights the role of this novel class for the management of diabetes in patients with acromegaly.
PMID: 30587461 [PubMed - as supplied by publisher]
Source: Trends in Endocrinology and Metabolism: TEM - Category: Endocrinology Authors: Adnan Z Tags: Trends Endocrinol Metab Source Type: research
More News: Acromegaly | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Hormones | Insulin | Sodium